Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

Stopped early · Phase 3

Conditions studied: Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Asthma

In brief

This trial is conducted in Europe, Asia, Oceania and the United States of America (USA). This is a one-year clinical trial to compare the safety of inhaled preprandial human insulin to subcutaneous insulin aspart in subjects with type 1 or 2 diabetes and asthma.

Key facts

Study ID

NCT00523042

Run by

Novo Nordisk A/S

People needed

10

Starts

2007-08-30

Expected to finish

2008-02-28

Last updated by the study team

2018-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 1 or type 2 diabetes
• Treatment with insulin and/or oral anti-diabetic drugs
• Asthma for at least 6 months
• Positive airway reversibility/bronchoprovocation test or documented positive test in the last 3 years
• HbA1C less than or equal to 11.0 %
• Body Mass Index (BMI) less than or equal to 40.0 kg/m2

You may not qualify if…

• Current smoking or smoking within the last 6 months
• Other current acute or chronic pulmonary disease excluding asthma
• Recurrent severe hypoglycaemia
• Proliferative retinopathy or maculopathy

Where it is running

• Novo Nordisk Investigational Site — Fresno, California, United States
• Novo Nordisk Investigational Site — New Orleans, Louisiana, United States
• Novo Nordisk Investigational Site — Kansas City, Missouri, United States
• Novo Nordisk Investigational Site — Columbus, Ohio, United States
• Novo Nordisk Investigational Site — Philadelphia, Pennsylvania, United States
• Novo Nordisk Investigational Site — Pittsburgh, Pennsylvania, United States
• Novo Nordisk Investigational Site — Houston, Texas, United States
• Novo Nordisk Investigational Site — Ogden, Utah, United States
• Novo Nordisk Investigational Site — Spokane, Washington, United States
• Novo Nordisk Investigational Site — Broadmeadow, New South Wales, Australia
• Novo Nordisk Investigational Site — Camperdown, New South Wales, Australia
• Novo Nordisk Investigational Site — Keswick, South Australia, Australia
• Novo Nordisk Investigational Site — Box Hill, Victoria, Australia
• Novo Nordisk Investigational Site — East Ringwood, Victoria, Australia
• Novo Nordisk Investigational Site — Parkville, Victoria, Australia
• Novo Nordisk Investigational Site — Auchenflower, Australia
• Novo Nordisk Investigational Site — Kippa-Ring, Australia
• Novo Nordisk Investigational Site — Chandigarh, Punjab, India
• Novo Nordisk Investigational Site — Vellore, Tamil Nadu, India
• Novo Nordisk Investigational Site — Kolkata, West Bengal, India
• Novo Nordisk Investigational Site — Hyderabad, India
• Novo Nordisk Investigational Site — Mumbai, India
• Novo Nordisk Investigational Site — Pune, India
• Novo Nordisk Investigational Site — Cheras, Malaysia
• Novo Nordisk Investigational Site — Kota Bharu, Kelantan, Malaysia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.